1. Home
  2. OPLN vs RCUS Comparison

OPLN vs RCUS Comparison

Compare OPLN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPENLANE Inc.

OPLN

OPENLANE Inc.

N/A

Current Price

$28.08

Market Cap

3.2B

Sector

N/A

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$24.04

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPLN
RCUS
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
OPLN
RCUS
Price
$28.08
$24.04
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$32.00
$28.22
AVG Volume (30 Days)
1.0M
949.7K
Earning Date
01-01-0001
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
$5.82
N/A
Revenue Next Year
$7.62
$19.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.81
$6.79
52 Week High
$31.78
$26.40

Technical Indicators

Market Signals
Indicator
OPLN
RCUS
Relative Strength Index (RSI) 45.13 64.56
Support Level $27.45 $20.35
Resistance Level $30.11 $24.16
Average True Range (ATR) 1.08 1.35
MACD 0.01 0.35
Stochastic Oscillator 54.99 87.79

Price Performance

Historical Comparison
OPLN
RCUS

About OPLN OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: